Cogent Biosciences Inc
(COGT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | COGT | AZN | AMGN | GILD | BMY |
| Company | Cogent Biosciences Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 36.84 | 205.64 | 362.65 | 151.89 | 60.11 |
| High | 37.60 | 206.71 | 370.39 | 156.95 | 60.94 |
| Low | 36.31 | 204.09 | 361.71 | 151.86 | 60.02 |
| Latest | 36.53 | 205.55 | 369.19 | 154.98 | 60.74 |
| Change | -0.19 | +1.03 | +2.99 | +3.17 | +0.88 |
| % Change | -0.52% | +0.50% | +0.82% | +2.09% | +1.47% |
| Volume | 1,033,039 | 2,503,412 | 2,402,763 | 6,785,575 | 10,758,668 |
| 20-Day Average Volume | 1,854,547 | 4,517,146 | 3,212,523 | 8,925,523 | 13,675,003 |
| Previous Close | 36.72 | 204.52 | 366.20 | 151.81 | 59.86 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 37.71 | 189.62 | 353.45 | 142.05 | 57.04 |
| 20-Day Raw Stochastic | 17.61% | 95.95% | 74.88% | 93.44% | 84.60% |
| 20-Day Relative Strength | 49.55 | 65.52 | 61.52 | 69.29 | 66.20 |
| Weighted Alpha | +116.09 | +49.13 | +33.73 | +59.72 | +24.36 |
| Today's Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 40% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 88% Buy | 100% Buy | 64% Buy | 72% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.48% since 02/06/26 | +6.49% since 02/06/26 | -3.94% since 02/06/26 | +1.63% since 02/06/26 | -2.02% since 02/06/26 |
| Low | 35.50 on 02/12/26 | 187.06 on 02/09/26 | 361.00 on 02/11/26 | 147.07 on 02/10/26 | 59.25 on 02/12/26 |
| High | 38.19 on 02/09/26 | 206.71 on 02/13/26 | 384.62 on 02/09/26 | 157.29 on 02/11/26 | 61.63 on 02/09/26 |
| 1-Month | |||||
| %Chg | +3.54% since 01/13/26 | +8.75% since 01/13/26 | +13.84% since 01/13/26 | +27.28% since 01/13/26 | +8.62% since 01/13/26 |
| Low | 35.08 on 01/14/26 | 178.08 on 01/21/26 | 321.71 on 01/20/26 | 120.94 on 01/15/26 | 53.54 on 01/21/26 |
| High | 41.35 on 01/16/26 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +7.98% since 11/13/25 | +15.99% since 11/13/25 | +9.88% since 11/13/25 | +23.79% since 11/13/25 | +24.90% since 11/13/25 |
| Low | 32.03 on 11/14/25 | 176.56 on 11/14/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 43.73 on 12/08/25 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | +204.92% since 08/13/25 | +31.86% since 08/13/25 | +27.60% since 08/13/25 | +29.00% since 08/13/25 | +26.94% since 08/13/25 |
| Low | 11.41 on 08/14/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 43.73 on 12/08/25 | 206.71 on 02/13/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 5,228,083 | 317,191,712 | 197,191,760 | 188,347,648 | 121,860,176 |
| Shares Outstanding, K | 142,377 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 36,751,000,000 | 28,754,000,000 | 48,194,000,000 |
| Annual Net Income | -255,860,000 | 7,035,000,000 | 7,711,000,000 | 480,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,866,000,000 | 7,769,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -80,930,000 | 2,533,000,000 | 1,333,000,000 | 3,052,000,000 | 1,087,000,000 |
| 60-Month Beta | 0.45 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.50 on 11/07/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/24/26 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.28 | 16.78 | 19.12 | 9.74 |